Cargando…

Outcomes Following the Use of Angiotensin II in Patients with Postoperative Vasoplegic Syndrome: A Case Series

Catecholamine-resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the treatment of vasodilatory shock; however, its use in PVS is not well described. We report outcomes in six patients receiving angiotensin II for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konkol, Samuel B., Morrisette, Matthew J., Hulse, Matthew C., Enfield, Kyle B., Mihalek, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387627/ https://www.ncbi.nlm.nih.gov/pubmed/35799569 http://dx.doi.org/10.4103/aca.aca_98_21

Ejemplares similares

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
por: Bendjelid, Karim
Publicado: (2020)

Complexities of Characterizing “Vasoplegics”
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018)

Vasoplegic syndrome in patients undergoing heart transplantation
por: Qin, Tong-xin, et al.
Publicado: (2023)

Vasoplegic Syndrome and Anaesthesia: A Narrative Review
por: Gökdemir, Begüm Nemika, et al.
Publicado: (2023)

Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
por: Busse, Laurence W., et al.
Publicado: (2020)

Definitions and pathophysiology of vasoplegic shock
por: Lambden, Simon, et al.
Publicado: (2018)

Reply to: Complexities of Characterizing Vasoplegics
por: Magoon, Rohan, et al.
Publicado: (2023)

Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)

Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis
por: Lim, Pascal, et al.
Publicado: (2022)

Comment on “Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options”
por: Ortoleva, Jamel, et al.
Publicado: (2020)

Vasopressin in vasoplegic shock: A systematic review
por: Webb, Andrew J, et al.
Publicado: (2020)

Very High Dose Epinephrine for the Treatment of Vasoplegic Syndrome during Liver Transplantation
por: Khosravi, M. B., et al.
Publicado: (2013)

Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study
por: Saleh, Mohamed, et al.
Publicado: (2020)

High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm
por: Cheungpasitporn, Wisit, et al.
Publicado: (2017)

Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
por: Mazzeffi, Michael, et al.
Publicado: (2017)

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
por: Ayers, Brian, et al.
Publicado: (2020)

Intravenous infusion of angiotensin II for treatment of cardiopulmonary bypass-induced vasoplegic shock after implantation of left ventricular assist device: a case report
por: Šribar, Andrej, et al.
Publicado: (2023)

Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised
por: Evora, Paulo Roberto Barbosa, et al.
Publicado: (2015)

The Efficacy of Albumin Dialysis in the Reversal of Refractory Vasoplegic Shock Due to Amlodipine Toxicity
por: Connor-Schuler, Randi L., et al.
Publicado: (2020)

Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care
por: Ltaief, Zied, et al.
Publicado: (2022)

Extended Duration Infusion of Hydroxocobalamin for Vasoplegic Rescue in Septic Shock
por: Gerdes, Harrison J, et al.
Publicado: (2021)

Role of plasminogen activator inhibitor-1 polymorphism on the development of vasoplegic syndrome associated with cardiopulmonary bypass
por: Jimenez, J, et al.
Publicado: (2007)

The Use of Intravenous Hydroxocobalamin as a Rescue in Methylene Blue-resistant Vasoplegic Syndrome in Cardiac Surgery
por: Cai, Yi, et al.
Publicado: (2017)

Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review
por: Mirhosseini, Seyed Mohsen, et al.
Publicado: (2017)

Vasoplegic Syndrome Post-cardiopulmonary Bypass in a Renal Transplant Patient: The Brain Is Not the Index Organ
por: Bennett, Sean R, et al.
Publicado: (2022)

Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass
por: Peyko, Vincent, et al.
Publicado: (2021)

Vasopressin in vasoplegic shock in surgical patients: systematic review and meta-analysis
por: Szeles, Taís Felix, et al.
Publicado: (2023)

Vasoplegic syndrome after cardiopulmonary bypass surgery – associated factors and clinical outcomes: a nested case-control study
por: Iribarren, J, et al.
Publicado: (2007)

Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery - A case report -
por: Oh, In Duk, et al.
Publicado: (2019)

Stratifying septic patients using lactate: severe sepsis and cryptic, vasoplegic and dysoxic shock profile
por: Ranzani, Otavio T, et al.
Publicado: (2013)

Vasopressin versus norepinephrine infusion in patients with vasoplegic shock after cardiac surgery
por: Hajjar, L, et al.
Publicado: (2009)

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
por: Manji, Farheen, et al.
Publicado: (2017)

Longer term hemodialysis-dependent chronic renal failure increases the risk of post-cardiac surgery vasoplegic syndrome
por: Suga, Masafumi, et al.
Publicado: (2020)

The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery
por: Petermichl, Walter, et al.
Publicado: (2021)

Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study
por: Kofler, Othmar, et al.
Publicado: (2022)

Successful treatment of intravenous drug abuser with refractory vasoplegic syndrome after mitral valve repair for infective endocarditis
por: Lambert, Jacob, et al.
Publicado: (2021)

Post-ICU COVID-19 Outcomes: A Case Series
por: Ramani, Chintan, et al.
Publicado: (2021)

After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

Dynamic data in the ED predict requirement for ICU transfer following acute care admission
por: Glass, George, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k9fkuqeie7tah51vqt4orpu2vq